![Sin-Young Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 2 M $ au 30/06/2026
Sin-Young Park currently works at OliX Pharmaceuticals, Inc., as Director & Senior Vice President from 2019 and Olix Us, Inc., as Vice President-Development.
Dr. Park received her graduate degree and doctorate degree from Seoul National University, undergraduate degree from Ewha Womans University, and graduate degree and doctorate degree from College of Pharmacy Seoul National University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/12/2025 | 20 000 ( 0,1 % ) | 2 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| OLIX PHARMACEUTICALS, INC | Directeur/Membre du Conseil | 19/03/2019 |
Olix Us, Inc. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ewha Womans University
 Ewha Womans University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Pharmacy Seoul National University
 College of Pharmacy Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OliX Pharmaceuticals, Inc.
 OliX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against locally treatable diseases | Health Technology |
Olix Us, Inc. | Electronic Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
